# Does a ThoracoLumbar Interfacial Plane (TLIP) Block With Liposomal Bupivacaine Provide TLIP Block in Spinal Surgery

> **NCT04865211** · PHASE2 · UNKNOWN · sponsor: **The Cooper Health System** · enrollment: 90 (estimated)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Liposomal bupivacaine
- **DRUG:** Bupivacaine Injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04865211
- **Lead sponsor:** The Cooper Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-05
- **Primary completion:** 2022-02-17
- **Final completion:** 2022-04-30
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2021-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04865211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04865211, "Does a ThoracoLumbar Interfacial Plane (TLIP) Block With Liposomal Bupivacaine Provide TLIP Block in Spinal Surgery". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04865211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*